- Home
- SYTA vs CING Comparison
SYTA vs CING Comparison
Compare SYTA & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- CING
- Stock Information
- Founded
- SYTA N/A
- CING 2012
- Country
- SYTA Canada
- CING United States
- Employees
- SYTA N/A
- CING N/A
- Industry
- SYTA Telecommunications Equipment
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- CING Health Care
- Exchange
- SYTA Nasdaq
- CING Nasdaq
- Market Cap
- SYTA 17.3M
- CING 16.2M
- IPO Year
- SYTA 2020
- CING 2021
- Fundamental
- Price
- SYTA $3.38
- CING $4.36
- Analyst Decision
- SYTA
- CING Strong Buy
- Analyst Count
- SYTA 0
- CING 4
- Target Price
- SYTA N/A
- CING $30.67
- AVG Volume (30 Days)
- SYTA 24.9M
- CING 250.6K
- Earning Date
- SYTA 05-15-2025
- CING 05-08-2025
- Dividend Yield
- SYTA N/A
- CING N/A
- EPS Growth
- SYTA N/A
- CING N/A
- EPS
- SYTA N/A
- CING N/A
- Revenue
- SYTA $11,740,024.00
- CING N/A
- Revenue This Year
- SYTA $18.41
- CING N/A
- Revenue Next Year
- SYTA N/A
- CING N/A
- P/E Ratio
- SYTA N/A
- CING N/A
- Revenue Growth
- SYTA 33.58
- CING N/A
- 52 Week Low
- SYTA $0.93
- CING $1.80
- 52 Week High
- SYTA $304.15
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- SYTA 50.26
- CING 61.94
- Support Level
- SYTA $3.00
- CING $3.81
- Resistance Level
- SYTA $8.87
- CING $4.09
- Average True Range (ATR)
- SYTA 1.45
- CING 0.26
- MACD
- SYTA -0.16
- CING 0.07
- Stochastic Oscillator
- SYTA 13.00
- CING 96.43
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.